Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for SP1
Z-value: 4.20
Motif logo
Transcription factors associated with SP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP1
|
ENSG00000185591.5 | Sp1 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP1 | hg19_v2_chr12_+_53774423_53774658 | -0.13 | 4.8e-01 | Click! |
Activity profile of SP1 motif
Sorted Z-values of SP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_+_43739697 | 9.50 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr11_+_64073022 | 7.09 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chrX_+_109245863 | 6.63 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr17_-_66453562 | 6.37 |
ENST00000262139.5
ENST00000546360.1 |
WIPI1
|
WD repeat domain, phosphoinositide interacting 1 |
| chr12_-_54982300 | 6.22 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr19_+_50706866 | 6.04 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
| chr6_-_4135693 | 5.92 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr20_+_33464368 | 5.74 |
ENST00000484354.1
ENST00000493805.2 ENST00000473172.1 |
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr19_-_39226045 | 5.72 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
| chr20_+_33464407 | 5.68 |
ENST00000253382.5
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr15_+_80445113 | 5.45 |
ENST00000407106.1
ENST00000261755.5 |
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr17_-_7155274 | 5.26 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr1_-_38471156 | 5.23 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
| chr3_-_48130314 | 5.15 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr20_-_3154162 | 5.03 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
| chr13_-_110438914 | 5.01 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr7_-_105925367 | 5.01 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr12_+_110718921 | 4.94 |
ENST00000308664.6
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr17_-_48943706 | 4.91 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
| chr6_-_4135825 | 4.91 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chrX_-_49041242 | 4.81 |
ENST00000453382.1
ENST00000540849.1 ENST00000536904.1 ENST00000432913.1 |
PRICKLE3
|
prickle homolog 3 (Drosophila) |
| chr2_+_27193480 | 4.80 |
ENST00000233121.2
ENST00000405074.3 |
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3 |
| chr18_+_11981427 | 4.63 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr19_-_40971643 | 4.59 |
ENST00000595483.1
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
| chr15_+_80445232 | 4.58 |
ENST00000561421.1
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr3_+_50654821 | 4.54 |
ENST00000457064.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chr5_-_114880533 | 4.54 |
ENST00000274457.3
|
FEM1C
|
fem-1 homolog c (C. elegans) |
| chr12_-_54982420 | 4.52 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr18_+_11981014 | 4.47 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr20_+_33464238 | 4.46 |
ENST00000360596.2
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr3_-_48130707 | 4.36 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
| chr3_+_50649302 | 4.36 |
ENST00000446044.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chrX_+_43515467 | 4.35 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
| chr4_+_152330409 | 4.34 |
ENST00000513086.1
|
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr19_-_2051223 | 4.28 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr12_+_53400176 | 4.25 |
ENST00000551002.1
ENST00000420463.3 ENST00000416762.3 ENST00000549481.1 ENST00000552490.1 |
EIF4B
|
eukaryotic translation initiation factor 4B |
| chr1_+_10092890 | 4.24 |
ENST00000253251.8
ENST00000377157.3 |
UBE4B
|
ubiquitination factor E4B |
| chr7_+_65338312 | 4.22 |
ENST00000434382.2
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
| chr6_+_3000218 | 4.21 |
ENST00000380441.1
ENST00000380455.4 ENST00000380454.4 |
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
| chr18_+_3449821 | 4.19 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr16_+_29817399 | 4.16 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr2_-_208634287 | 4.15 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
| chr13_-_76056250 | 4.15 |
ENST00000377636.3
ENST00000431480.2 ENST00000377625.2 ENST00000425511.1 |
TBC1D4
|
TBC1 domain family, member 4 |
| chr7_+_97910962 | 4.07 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
| chr18_+_11981547 | 4.07 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr11_-_130184555 | 4.07 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chr6_+_44095347 | 4.06 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr19_-_2050852 | 4.01 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr6_+_149638876 | 3.99 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr19_-_40971667 | 3.95 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
| chr7_-_51384451 | 3.95 |
ENST00000441453.1
ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL
|
cordon-bleu WH2 repeat protein |
| chr1_+_154975110 | 3.95 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chrX_+_135229559 | 3.93 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr14_-_21566731 | 3.93 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr19_+_35532612 | 3.93 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr12_+_121163602 | 3.90 |
ENST00000411593.2
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr6_+_64282447 | 3.88 |
ENST00000370650.2
ENST00000578299.1 |
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr9_-_35115836 | 3.88 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
| chr19_-_11456935 | 3.88 |
ENST00000590788.1
ENST00000586590.1 ENST00000589555.1 ENST00000586956.1 ENST00000593256.2 ENST00000447337.1 ENST00000591677.1 ENST00000586701.1 ENST00000589655.1 |
TMEM205
RAB3D
|
transmembrane protein 205 RAB3D, member RAS oncogene family |
| chr6_-_34664612 | 3.86 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
| chr3_-_113415441 | 3.85 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr12_+_57522692 | 3.84 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr2_-_178129551 | 3.81 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
| chr6_+_3000195 | 3.78 |
ENST00000338130.2
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
| chr4_+_1003742 | 3.75 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr19_-_46000251 | 3.74 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
| chr11_-_17410629 | 3.73 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr1_-_9189229 | 3.72 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr3_+_50654550 | 3.71 |
ENST00000430409.1
ENST00000357955.2 |
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chr17_+_55333876 | 3.71 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
| chr12_-_58131931 | 3.70 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
| chr14_+_21945335 | 3.69 |
ENST00000262709.3
ENST00000457430.2 ENST00000448790.2 |
TOX4
|
TOX high mobility group box family member 4 |
| chr7_-_105925558 | 3.68 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr2_+_44396000 | 3.68 |
ENST00000409895.4
ENST00000409432.3 ENST00000282412.4 ENST00000378551.2 ENST00000345249.4 |
PPM1B
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
| chr9_-_126692386 | 3.67 |
ENST00000373624.2
ENST00000394219.3 ENST00000373620.3 ENST00000394215.2 ENST00000373618.1 |
DENND1A
|
DENN/MADD domain containing 1A |
| chr3_-_88108212 | 3.67 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr19_+_33166313 | 3.66 |
ENST00000334176.3
|
RGS9BP
|
regulator of G protein signaling 9 binding protein |
| chr1_+_10093188 | 3.65 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
| chr6_-_44095183 | 3.65 |
ENST00000372014.3
|
MRPL14
|
mitochondrial ribosomal protein L14 |
| chr2_+_48541776 | 3.65 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
| chr10_-_104001231 | 3.64 |
ENST00000370002.3
|
PITX3
|
paired-like homeodomain 3 |
| chr6_+_44095263 | 3.63 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
| chr2_-_240322685 | 3.62 |
ENST00000544989.1
|
HDAC4
|
histone deacetylase 4 |
| chr20_+_30407105 | 3.60 |
ENST00000375994.2
|
MYLK2
|
myosin light chain kinase 2 |
| chr12_-_42631529 | 3.59 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
| chr20_+_30407151 | 3.59 |
ENST00000375985.4
|
MYLK2
|
myosin light chain kinase 2 |
| chr10_+_11784360 | 3.56 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr17_-_7155775 | 3.54 |
ENST00000571409.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr17_+_6926381 | 3.53 |
ENST00000576705.1
|
BCL6B
|
B-cell CLL/lymphoma 6, member B |
| chr12_+_100660909 | 3.53 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr11_+_66234216 | 3.52 |
ENST00000349459.6
ENST00000320740.7 ENST00000524466.1 ENST00000526296.1 |
PELI3
|
pellino E3 ubiquitin protein ligase family member 3 |
| chr16_+_5008290 | 3.52 |
ENST00000251170.7
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
| chr12_+_54694979 | 3.51 |
ENST00000552848.1
|
COPZ1
|
coatomer protein complex, subunit zeta 1 |
| chr12_+_100660940 | 3.50 |
ENST00000548392.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr12_+_53399942 | 3.49 |
ENST00000262056.9
|
EIF4B
|
eukaryotic translation initiation factor 4B |
| chr20_-_62130474 | 3.49 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr7_+_36192855 | 3.48 |
ENST00000534978.1
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chr19_+_6739662 | 3.48 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chrX_-_108976410 | 3.46 |
ENST00000504980.1
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
| chr10_+_120789223 | 3.44 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
| chrX_+_135229731 | 3.44 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chr19_-_11456872 | 3.43 |
ENST00000586218.1
|
TMEM205
|
transmembrane protein 205 |
| chr6_+_43737939 | 3.42 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
| chr12_+_110719032 | 3.42 |
ENST00000395494.2
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr17_+_4854375 | 3.42 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
| chr7_-_129592700 | 3.41 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr19_-_55791431 | 3.39 |
ENST00000593263.1
ENST00000376343.3 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
| chr6_-_167040693 | 3.38 |
ENST00000366863.2
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
| chr19_-_4065730 | 3.38 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
| chr19_+_50879705 | 3.37 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
| chr3_+_49507559 | 3.37 |
ENST00000421560.1
ENST00000308775.2 ENST00000545947.1 ENST00000541308.1 ENST00000539901.1 ENST00000538711.1 ENST00000418588.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr19_-_42759266 | 3.36 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
| chr14_-_74551096 | 3.35 |
ENST00000350259.4
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr22_-_39548511 | 3.34 |
ENST00000434260.1
|
CBX7
|
chromobox homolog 7 |
| chr3_-_24536453 | 3.33 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
| chrX_+_135229600 | 3.33 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr17_-_49198095 | 3.33 |
ENST00000505279.1
|
SPAG9
|
sperm associated antigen 9 |
| chr9_-_112260531 | 3.32 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
| chr22_+_38597889 | 3.31 |
ENST00000338483.2
ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
| chr19_-_18392422 | 3.30 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
| chr7_+_97910981 | 3.29 |
ENST00000297290.3
|
BRI3
|
brain protein I3 |
| chr19_-_11456905 | 3.29 |
ENST00000588560.1
ENST00000592952.1 |
TMEM205
|
transmembrane protein 205 |
| chr14_+_105190514 | 3.29 |
ENST00000330877.2
|
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr19_-_11457162 | 3.28 |
ENST00000590482.1
|
TMEM205
|
transmembrane protein 205 |
| chr12_+_57522439 | 3.27 |
ENST00000338962.4
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr2_-_220118631 | 3.27 |
ENST00000248437.4
|
TUBA4A
|
tubulin, alpha 4a |
| chr16_-_1993124 | 3.26 |
ENST00000473663.1
ENST00000399753.2 ENST00000564908.1 |
MSRB1
|
methionine sulfoxide reductase B1 |
| chr11_-_111783595 | 3.25 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr22_+_35695793 | 3.24 |
ENST00000456128.1
ENST00000449058.2 ENST00000411850.1 ENST00000425375.1 ENST00000436462.2 ENST00000382034.5 |
TOM1
|
target of myb1 (chicken) |
| chr4_+_152330390 | 3.23 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chrX_-_108976521 | 3.22 |
ENST00000469796.2
ENST00000502391.1 ENST00000508092.1 ENST00000340800.2 ENST00000348502.6 |
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
| chr19_-_17356697 | 3.22 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
| chr5_+_148521454 | 3.20 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr5_+_78985673 | 3.19 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr17_+_7348374 | 3.19 |
ENST00000306071.2
ENST00000572857.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr4_-_185747188 | 3.18 |
ENST00000507295.1
ENST00000504900.1 ENST00000281455.2 ENST00000454703.2 |
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
| chr17_-_7155802 | 3.17 |
ENST00000572043.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr19_+_47778119 | 3.17 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
| chr12_+_48513009 | 3.17 |
ENST00000359794.5
ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM
|
phosphofructokinase, muscle |
| chr19_+_47760777 | 3.15 |
ENST00000599398.1
ENST00000595659.1 |
CCDC9
|
coiled-coil domain containing 9 |
| chrX_-_135056106 | 3.15 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
| chr11_-_130184470 | 3.14 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chr3_-_88108192 | 3.14 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr6_-_70506963 | 3.14 |
ENST00000370577.3
|
LMBRD1
|
LMBR1 domain containing 1 |
| chr19_+_17581253 | 3.14 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
| chr7_-_129592471 | 3.13 |
ENST00000473814.2
ENST00000490974.1 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr3_+_9834227 | 3.13 |
ENST00000287613.7
ENST00000397261.3 |
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
| chr11_-_2906979 | 3.12 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chr7_+_128864848 | 3.11 |
ENST00000325006.3
ENST00000446544.2 |
AHCYL2
|
adenosylhomocysteinase-like 2 |
| chr19_+_56653064 | 3.10 |
ENST00000593100.1
|
ZNF444
|
zinc finger protein 444 |
| chr1_+_167905894 | 3.10 |
ENST00000367843.3
ENST00000432587.2 ENST00000312263.6 |
DCAF6
|
DDB1 and CUL4 associated factor 6 |
| chr16_-_75150665 | 3.10 |
ENST00000300051.4
ENST00000450168.2 |
LDHD
|
lactate dehydrogenase D |
| chr20_+_34894247 | 3.10 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
| chr19_+_13056663 | 3.09 |
ENST00000541222.1
ENST00000316856.3 ENST00000586534.1 ENST00000592268.1 |
RAD23A
|
RAD23 homolog A (S. cerevisiae) |
| chr1_-_23751189 | 3.08 |
ENST00000374601.3
ENST00000450454.2 |
TCEA3
|
transcription elongation factor A (SII), 3 |
| chr19_-_56135928 | 3.08 |
ENST00000591479.1
ENST00000325351.4 |
ZNF784
|
zinc finger protein 784 |
| chr11_+_12696102 | 3.08 |
ENST00000527636.1
ENST00000527376.1 |
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
| chr19_+_8478154 | 3.06 |
ENST00000381035.4
ENST00000595142.1 ENST00000601724.1 ENST00000393944.1 ENST00000215555.2 ENST00000601283.1 ENST00000595213.1 |
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr1_+_178994939 | 3.06 |
ENST00000440702.1
|
FAM20B
|
family with sequence similarity 20, member B |
| chr1_-_17445930 | 3.06 |
ENST00000375486.4
ENST00000375481.1 ENST00000444885.2 |
PADI2
|
peptidyl arginine deiminase, type II |
| chr16_+_56691838 | 3.06 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
| chr4_-_129209221 | 3.05 |
ENST00000512483.1
|
PGRMC2
|
progesterone receptor membrane component 2 |
| chr1_+_211432775 | 3.04 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
| chr1_-_53019059 | 3.03 |
ENST00000484723.2
ENST00000524582.1 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr5_+_148521381 | 3.02 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr17_-_56591978 | 3.00 |
ENST00000583656.1
|
MTMR4
|
myotubularin related protein 4 |
| chr21_+_47743995 | 2.99 |
ENST00000359568.5
|
PCNT
|
pericentrin |
| chr2_+_5832799 | 2.99 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
| chr14_+_24600484 | 2.99 |
ENST00000267426.5
|
FITM1
|
fat storage-inducing transmembrane protein 1 |
| chr7_+_36192758 | 2.98 |
ENST00000242108.4
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chrX_+_109246285 | 2.98 |
ENST00000372073.1
ENST00000372068.2 ENST00000288381.4 |
TMEM164
|
transmembrane protein 164 |
| chr7_-_105926058 | 2.97 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr7_-_102257139 | 2.97 |
ENST00000521076.1
ENST00000462172.1 ENST00000522801.1 ENST00000449970.2 ENST00000262940.7 |
RASA4
|
RAS p21 protein activator 4 |
| chr10_-_103599591 | 2.96 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
| chr5_-_141257954 | 2.95 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr6_+_108882069 | 2.95 |
ENST00000406360.1
|
FOXO3
|
forkhead box O3 |
| chr12_-_6715808 | 2.94 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr17_+_21188012 | 2.94 |
ENST00000529517.1
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr1_-_202936394 | 2.93 |
ENST00000367249.4
|
CYB5R1
|
cytochrome b5 reductase 1 |
| chr19_-_14201507 | 2.93 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr1_-_9189144 | 2.93 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
| chr6_-_160114260 | 2.92 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr1_-_45140227 | 2.92 |
ENST00000372237.3
|
TMEM53
|
transmembrane protein 53 |
| chr7_+_73868220 | 2.92 |
ENST00000455841.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr1_+_169075554 | 2.92 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr8_+_1711918 | 2.92 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| chr20_+_48807351 | 2.91 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr12_+_51158263 | 2.91 |
ENST00000539132.1
ENST00000552487.1 |
ATF1
|
activating transcription factor 1 |
| chr12_+_109592477 | 2.91 |
ENST00000544726.1
|
ACACB
|
acetyl-CoA carboxylase beta |
| chr14_-_21493649 | 2.91 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
| chr3_-_50649192 | 2.91 |
ENST00000443053.2
ENST00000348721.3 |
CISH
|
cytokine inducible SH2-containing protein |
| chr19_-_14201776 | 2.90 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr17_+_7348658 | 2.90 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr22_-_41940404 | 2.89 |
ENST00000355209.4
ENST00000337566.5 ENST00000396504.2 ENST00000407461.1 |
POLR3H
|
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) |
| chr3_+_135684515 | 2.89 |
ENST00000264977.3
ENST00000490467.1 |
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
| chr6_-_160114293 | 2.87 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr16_-_1993260 | 2.87 |
ENST00000361871.3
|
MSRB1
|
methionine sulfoxide reductase B1 |
| chr1_+_207226574 | 2.87 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
| chr19_+_3359561 | 2.87 |
ENST00000589123.1
ENST00000346156.5 ENST00000395111.3 ENST00000586919.1 |
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor) |
| chr18_+_3449695 | 2.87 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.9 | 14.6 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 3.6 | 10.8 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.7 | 16.2 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 2.2 | 6.7 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 2.0 | 8.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 2.0 | 5.9 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 1.9 | 15.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 1.9 | 9.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.9 | 7.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.8 | 5.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.7 | 1.7 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 1.7 | 7.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.7 | 8.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.6 | 4.9 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 1.6 | 7.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.6 | 7.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.5 | 7.7 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 1.5 | 4.6 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.5 | 7.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.5 | 4.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.5 | 4.4 | GO:0044209 | AMP salvage(GO:0044209) |
| 1.4 | 4.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.4 | 5.6 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.4 | 8.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.4 | 12.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.4 | 5.5 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 1.4 | 9.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.4 | 4.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.4 | 4.1 | GO:1990036 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 1.3 | 4.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.3 | 4.0 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 1.3 | 10.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.3 | 5.2 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.3 | 6.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 1.3 | 3.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.3 | 13.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 1.2 | 1.2 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 1.2 | 3.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.2 | 4.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 1.2 | 2.5 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 1.2 | 8.5 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.2 | 10.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.2 | 11.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.2 | 9.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.2 | 1.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.2 | 6.9 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.2 | 2.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 1.1 | 8.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.1 | 6.9 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 1.1 | 4.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.1 | 4.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 | 10.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 1.1 | 5.7 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 1.1 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.1 | 2.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 1.1 | 2.2 | GO:0090316 | positive regulation of intracellular protein transport(GO:0090316) |
| 1.1 | 3.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.1 | 5.4 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.1 | 7.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.1 | 11.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.1 | 4.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 | 3.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 1.1 | 5.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.0 | 9.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 1.0 | 4.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.0 | 3.1 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 1.0 | 3.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.0 | 4.1 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.0 | 4.1 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 1.0 | 5.1 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.0 | 16.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.0 | 4.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 1.0 | 3.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 1.0 | 11.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.0 | 3.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.0 | 5.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.0 | 3.0 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.0 | 4.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.0 | 3.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 1.0 | 6.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 1.0 | 1.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.0 | 3.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.0 | 3.9 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 1.0 | 4.9 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.0 | 2.9 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 1.0 | 1.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
| 1.0 | 14.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.9 | 5.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.9 | 0.9 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.9 | 2.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.9 | 0.9 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.9 | 20.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.9 | 3.7 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.9 | 3.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.9 | 21.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.9 | 0.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.9 | 4.5 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 0.9 | 4.5 | GO:0015862 | uridine transport(GO:0015862) |
| 0.9 | 0.9 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.9 | 3.5 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.9 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.9 | 1.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.9 | 3.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 12.2 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.9 | 11.3 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.9 | 7.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.9 | 3.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.9 | 4.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.9 | 2.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.9 | 5.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.9 | 10.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.8 | 5.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.8 | 4.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.8 | 2.5 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.8 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.8 | 2.5 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.8 | 6.7 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.8 | 1.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.8 | 2.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.8 | 6.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.8 | 4.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.8 | 7.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.8 | 3.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.8 | 2.4 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.8 | 2.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.8 | 4.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.8 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.8 | 2.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.8 | 0.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.8 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.8 | 7.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.8 | 3.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.8 | 0.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.8 | 5.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.8 | 1.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.8 | 10.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.8 | 8.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.8 | 23.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.8 | 8.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.8 | 3.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.8 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.8 | 0.8 | GO:0014855 | striated muscle cell proliferation(GO:0014855) |
| 0.8 | 3.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.8 | 3.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.8 | 3.1 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.8 | 2.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.8 | 6.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.8 | 3.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.8 | 13.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.8 | 5.3 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.8 | 0.8 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.7 | 3.7 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.7 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.7 | 3.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.7 | 9.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 | 3.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.7 | 1.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.7 | 2.9 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.7 | 2.9 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.7 | 1.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.7 | 0.7 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.7 | 3.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 11.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.7 | 2.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.7 | 6.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.7 | 4.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 | 2.8 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.7 | 7.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.7 | 2.1 | GO:1903489 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 0.7 | 1.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.7 | 2.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.7 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.7 | 4.2 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.7 | 6.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.7 | 2.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.7 | 2.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.7 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 | 5.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.7 | 6.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.7 | 3.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.7 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.7 | 2.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.7 | 2.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.7 | 2.7 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.7 | 5.4 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.7 | 8.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.7 | 2.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.7 | 0.7 | GO:1902309 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.7 | 1.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 | 4.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 3.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 | 7.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.7 | 6.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.7 | 2.0 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.7 | 11.9 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.7 | 8.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.7 | 4.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.7 | 2.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.7 | 3.9 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.7 | 4.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.7 | 2.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.6 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.6 | 3.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.6 | 1.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 3.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.6 | 6.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.6 | 1.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.6 | 13.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.6 | 5.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.6 | 1.9 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.6 | 4.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.6 | 10.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.6 | 5.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.6 | 1.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.6 | 4.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.6 | 1.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.6 | 3.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.6 | 6.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.6 | 6.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.6 | 6.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.6 | 1.9 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.6 | 4.9 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.6 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.6 | 0.6 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.6 | 4.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 3.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.6 | 3.6 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.6 | 3.6 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.6 | 9.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.6 | 1.8 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.6 | 1.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.6 | 4.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.6 | 2.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.6 | 1.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 | 8.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.6 | 1.2 | GO:0014009 | glial cell proliferation(GO:0014009) |
| 0.6 | 1.2 | GO:1903308 | regulation of chromatin modification(GO:1903308) |
| 0.6 | 1.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 1.8 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.6 | 0.6 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.6 | 3.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.6 | 1.8 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.6 | 1.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.6 | 3.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.6 | 4.7 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.6 | 3.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.6 | 5.3 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.6 | 1.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 | 5.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.6 | 1.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.6 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.6 | 2.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.6 | 1.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.6 | 3.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.6 | 4.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.6 | 3.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 2.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.6 | 2.3 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.6 | 0.6 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.6 | 5.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.6 | 9.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.6 | 7.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.6 | 9.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.6 | 4.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 | 2.2 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.6 | 3.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.6 | 2.2 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.6 | 2.2 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.6 | 0.6 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.6 | 14.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.6 | 0.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.6 | 5.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 | 5.5 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.5 | 3.8 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.5 | 2.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.5 | 2.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.5 | 6.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.5 | 3.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.5 | 0.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.5 | 4.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.5 | 1.6 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.5 | 1.6 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.5 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 | 2.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.5 | 6.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.5 | 8.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.5 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.5 | 10.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.5 | 22.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.5 | 1.6 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 | 15.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.5 | 10.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.5 | 1.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.5 | 2.6 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.5 | 1.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.5 | 0.5 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.5 | 1.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.5 | 2.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 5.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.5 | 11.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 0.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.5 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.5 | 2.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.5 | 3.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 | 1.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.5 | 1.5 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.5 | 2.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 1.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.5 | 1.5 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.5 | 0.5 | GO:0070613 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
| 0.5 | 2.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 | 1.0 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.5 | 1.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 5.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 | 1.5 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.5 | 3.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 3.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.5 | 1.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
| 0.5 | 5.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 0.5 | 2.5 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.5 | 2.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.5 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.5 | 5.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.5 | 1.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.5 | 1.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 | 0.5 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.5 | 2.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.5 | 5.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.5 | 1.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 | 5.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.5 | 0.5 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.5 | 3.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.5 | 4.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.5 | 1.9 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.5 | 1.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.5 | 3.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 6.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.5 | 0.9 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.5 | 1.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.5 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.5 | 2.8 | GO:2001153 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.5 | 10.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.5 | 13.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.5 | 2.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.5 | 2.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 | 3.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.5 | 0.9 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.5 | 1.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 | 3.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.5 | 1.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.5 | 0.9 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.5 | 1.8 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 | 3.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 | 2.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.5 | 1.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 | 0.9 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.5 | 1.4 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 1.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.4 | 2.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 | 1.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.4 | 7.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 6.7 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.4 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 1.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 0.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.4 | 2.7 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.4 | 4.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.4 | 4.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 | 2.2 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
| 0.4 | 11.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 5.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.4 | 3.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.4 | 7.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 | 4.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 | 39.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.4 | 0.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.4 | 2.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.4 | 3.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 | 1.7 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 | 0.9 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.4 | 2.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 0.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 8.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 | 1.3 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.4 | 5.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 1.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 | 2.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.4 | 2.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.4 | 2.6 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.4 | 0.4 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.4 | 3.9 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.4 | 4.7 | GO:0000050 | urea cycle(GO:0000050) |
| 0.4 | 2.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.4 | 1.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.4 | 2.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.4 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.4 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 3.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.4 | 0.8 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.4 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 | 1.3 | GO:1904640 | response to methionine(GO:1904640) |
| 0.4 | 2.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.4 | 2.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 2.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 4.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.4 | 4.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.4 | 3.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.4 | 7.0 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 1.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 | 1.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.4 | 3.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.4 | 4.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.4 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 0.8 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.4 | 2.0 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.4 | 4.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 2.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.4 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.4 | 10.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.4 | 2.0 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.4 | 2.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.4 | 6.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 | 2.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 0.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.4 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.4 | 4.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.4 | 0.4 | GO:0036017 | response to erythropoietin(GO:0036017) |
| 0.4 | 2.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 | 4.8 | GO:0007512 | adult heart development(GO:0007512) |
| 0.4 | 0.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.4 | 9.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.4 | 1.6 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.4 | 1.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.4 | 2.8 | GO:0060356 | leucine import(GO:0060356) |
| 0.4 | 1.6 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.4 | 2.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 2.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 0.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.4 | 14.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 11.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 2.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 1.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.4 | 3.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.4 | 3.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 | 3.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 1.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.4 | 11.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.4 | 5.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 | 1.2 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 10.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.4 | 0.8 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.4 | 3.5 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.4 | 1.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.4 | 0.4 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 1.2 | GO:0018201 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 3.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 3.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 3.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.4 | 1.1 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.4 | 1.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 1.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 | 1.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.4 | 6.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.4 | 1.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 4.5 | GO:0042407 | cristae formation(GO:0042407) |
| 0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
| 0.4 | 2.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.4 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.4 | 1.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.4 | 6.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.4 | 3.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 1.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 | 1.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.4 | 5.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.4 | 1.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.4 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 0.4 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.4 | 0.7 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.4 | 3.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.4 | 2.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.4 | 1.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
| 0.4 | 4.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 | 4.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.4 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.4 | 6.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 2.9 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.4 | 4.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 | 0.4 | GO:0055001 | muscle cell development(GO:0055001) |
| 0.4 | 1.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 | 4.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.4 | 3.2 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.4 | 4.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.4 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.4 | 0.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 2.5 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.4 | 7.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 | 1.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 0.7 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.4 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.4 | 0.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 2.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 3.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.4 | 2.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.4 | 0.7 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.4 | 1.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 | 1.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.4 | 2.8 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 | 13.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.4 | 1.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.4 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 4.9 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.4 | 1.8 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 | 9.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 1.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.3 | 6.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 1.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.3 | 0.3 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.3 | 2.1 | GO:0018032 | protein amidation(GO:0018032) |
| 0.3 | 1.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.3 | 1.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.3 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.3 | 1.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 7.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.3 | 3.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 0.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.3 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 2.1 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 | 1.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 1.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 | 1.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.3 | 1.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.3 | 1.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.3 | 2.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.3 | 1.0 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.3 | 0.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.3 | 2.0 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.3 | 4.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.3 | 1.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 1.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.3 | 4.4 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.3 | 2.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 | 1.4 | GO:0006282 | regulation of DNA repair(GO:0006282) |
| 0.3 | 1.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 1.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.3 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.3 | 1.0 | GO:0017145 | stem cell division(GO:0017145) |
| 0.3 | 1.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 1.7 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 5.0 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.3 | 0.7 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 | 2.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 | 11.3 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 | 0.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.3 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 1.3 | GO:0014745 | negative regulation of muscle hyperplasia(GO:0014740) negative regulation of muscle adaptation(GO:0014745) smooth muscle hyperplasia(GO:0014806) |
| 0.3 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 9.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.3 | 1.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.3 | 4.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 | 0.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 2.0 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 | 0.3 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.3 | 1.3 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.3 | 1.3 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 | 8.9 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 2.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
| 0.3 | 2.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 1.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 | 5.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 1.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.3 | 1.0 | GO:0032765 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 0.3 | 11.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 2.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 | 3.9 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 2.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.3 | 1.3 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.3 | 1.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 | 0.6 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.3 | 1.6 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.3 | 0.6 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.3 | 4.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 7.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.3 | 6.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 | 1.0 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 0.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.3 | 0.6 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.3 | 6.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 0.6 | GO:0070988 | demethylation(GO:0070988) |
| 0.3 | 31.8 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.3 | 3.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 | 2.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.3 | 3.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 14.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.3 | 1.9 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
| 0.3 | 1.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 | 6.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 | 2.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
| 0.3 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 1.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.3 | 1.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 4.6 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
| 0.3 | 2.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.3 | 0.6 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-ornithine transmembrane transport(GO:1903352) L-arginine transmembrane transport(GO:1903400) L-lysine import into cell(GO:1903410) |
| 0.3 | 2.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 1.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.3 | 1.5 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
| 0.3 | 1.8 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.3 | 8.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 | 5.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.3 | 8.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.3 | 0.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.3 | 0.3 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 | 1.8 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.3 | 0.3 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.3 | 1.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.3 | 1.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 9.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.3 | 7.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.3 | 2.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.3 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 1.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 1.2 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.3 | 0.3 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 | 4.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.3 | 1.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 | 0.9 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.3 | 4.8 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 | 3.9 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.3 | 2.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.3 | 0.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.3 | 4.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 0.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.3 | 1.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.3 | 1.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.3 | 1.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.3 | 2.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 3.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.3 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.3 | 0.9 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.3 | 1.8 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 3.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.3 | 3.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 0.6 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.3 | 0.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.3 | 1.5 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.3 | 1.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 2.9 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
| 0.3 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.3 | 4.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.3 | 0.9 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.3 | 2.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 1.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 | 2.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.3 | 2.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.3 | 5.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.3 | 1.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.3 | 1.4 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.3 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.3 | 2.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 3.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.3 | 2.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.3 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 0.9 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.3 | 2.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.3 | 1.4 | GO:0009188 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.3 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.3 | 19.2 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.3 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 | 0.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.3 | 0.3 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.3 | 1.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 | 2.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 | 8.3 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.3 | 10.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.3 | 2.5 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.3 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 0.6 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.3 | 3.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 0.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.3 | 1.1 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 | 2.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 | 1.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.3 | 0.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 | 3.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.3 | 2.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.3 | 0.8 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.3 | 3.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.3 | 8.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 10.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.3 | 1.3 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.3 | 1.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.3 | 1.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.3 | 1.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 | 2.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 1.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.3 | 1.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 2.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.3 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 7.1 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 | 0.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.3 | 0.3 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
| 0.3 | 5.2 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.3 | 0.8 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.3 | 0.5 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.3 | 12.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.3 | 0.5 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 1.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.3 | 3.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.3 | 0.8 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 0.3 | GO:0032618 | interleukin-15 production(GO:0032618) |
| 0.3 | 1.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.3 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 | 2.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 0.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.3 | 30.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.2 | 1.2 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 | 1.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 | 2.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 2.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.2 | 1.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.2 | 1.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 0.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.2 | 17.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.2 | 3.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 | 2.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.2 | 5.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 | 0.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.2 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.2 | 0.7 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.2 | 1.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 1.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 0.7 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.2 | 1.2 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 | 0.7 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 0.7 | GO:0090102 | cochlea development(GO:0090102) |
| 0.2 | 1.0 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 0.2 | 0.5 | GO:0000423 | macromitophagy(GO:0000423) |
| 0.2 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.2 | 1.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 4.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
| 0.2 | 0.7 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) |
| 0.2 | 1.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 | 2.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 | 0.7 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 | 0.7 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 5.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 8.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.2 | 4.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.2 | 0.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
| 0.2 | 1.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 5.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.2 | 0.2 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
| 0.2 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 | 9.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 1.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.2 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
| 0.2 | 2.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 7.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 0.9 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 | 0.5 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 1.2 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 | 5.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.2 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 0.5 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 | 0.7 | GO:0060717 | chorion development(GO:0060717) |
| 0.2 | 34.6 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.2 | 5.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.2 | 7.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 0.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.2 | 0.7 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.2 | 24.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.2 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 3.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.2 | 1.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.2 | 0.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 2.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 | 7.0 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.2 | 2.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.2 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.2 | 6.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.2 | 1.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 2.0 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 2.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 | 1.1 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
| 0.2 | 0.9 | GO:0046056 | dADP metabolic process(GO:0046056) |
| 0.2 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 4.0 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 0.9 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 1.1 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.2 | 1.1 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 | 2.0 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
| 0.2 | 2.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.2 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.2 | 2.2 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 2.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 1.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 23.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 1.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 | 2.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 | 0.7 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.2 | 0.2 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 | 5.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.2 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 5.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.2 | 13.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 | 0.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 1.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 2.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.2 | 1.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.2 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 1.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.2 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 4.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.2 | 1.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
| 0.2 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.2 | 0.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 1.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 14.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.2 | 2.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 0.8 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.2 | 0.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 6.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.2 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 1.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 1.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 0.4 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.2 | 1.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 | 0.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.2 | 4.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 | 0.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 | 1.8 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.2 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.2 | 2.6 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.2 | 0.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 1.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 | 1.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.2 | 1.0 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.2 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.2 | 0.2 | GO:0050893 | sensory processing(GO:0050893) |
| 0.2 | 15.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 3.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 1.2 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.2 | 4.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 0.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 0.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 6.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.2 | 3.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 2.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.2 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 2.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 | 1.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 3.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 2.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 0.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 0.9 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.2 | 3.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 | 0.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.2 | 3.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.2 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 | 1.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.2 | 1.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 0.4 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
| 0.2 | 4.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.2 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 1.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.2 | 0.4 | GO:0052552 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 | 1.6 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 0.2 | 0.7 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.2 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 0.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.2 | 0.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 1.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 2.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.2 | 5.1 | GO:0019674 | NAD metabolic process(GO:0019674) |
| 0.2 | 4.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.2 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.2 | 5.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 1.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.2 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.2 | 0.7 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.2 | 1.8 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.2 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 3.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 1.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 1.1 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 0.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 | 0.7 | GO:0042401 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.2 | 5.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.2 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 0.9 | GO:0070829 | response to vitamin B2(GO:0033274) chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.2 | 3.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.2 | 0.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.2 | 0.5 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.2 | 0.3 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.2 | 1.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.2 | 18.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 | 0.3 | GO:0070781 | response to biotin(GO:0070781) |
| 0.2 | 1.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 2.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 2.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 0.3 | GO:0099627 | neurotransmitter receptor cycle(GO:0099627) |
| 0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.2 | 2.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.2 | 0.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.2 | 1.9 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 | 1.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.2 | 0.3 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.2 | 0.7 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 | 1.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 5.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.2 | 1.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.2 | 1.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 1.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.2 | 33.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.2 | 1.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.2 | 2.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 5.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.2 | 1.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.2 | 0.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.2 | 1.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 | 6.7 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.2 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 1.1 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 | 2.8 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 0.5 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.2 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.2 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 | 2.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 1.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.2 | 1.3 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.2 | 0.5 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.2 | 1.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 2.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 0.2 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.2 | 3.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 1.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 0.6 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.2 | 1.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.2 | 2.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 1.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.2 | 3.3 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.2 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 4.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 1.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 0.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 | 4.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 0.6 | GO:0097049 | motor neuron apoptotic process(GO:0097049) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 3.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 0.9 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 | 1.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 | 1.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.2 | 0.5 | GO:0032375 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.2 | 0.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 1.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 2.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.2 | 2.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 1.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 0.8 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.2 | 1.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 3.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.2 | 0.9 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.2 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 0.9 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 1.8 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.1 | 1.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
| 0.1 | 3.1 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.1 | 0.4 | GO:0051384 | response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.1 | 4.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 1.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 1.0 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 2.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 2.3 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 3.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 0.4 | GO:0003170 | heart valve development(GO:0003170) |
| 0.1 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 3.6 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.1 | 0.3 | GO:0097286 | iron ion import(GO:0097286) |
| 0.1 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.1 | 5.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 11.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 | 1.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 8.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 1.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 2.1 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 | 7.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.1 | 1.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 4.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 2.8 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 | 1.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 3.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 | 0.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.5 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 | 0.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 1.9 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
| 0.1 | 1.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 3.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 1.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 2.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 1.9 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.1 | 1.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 7.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 3.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 4.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 | 1.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 7.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.1 | 0.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 2.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.7 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 3.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 3.6 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.1 | 0.5 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 2.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.1 | 3.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 1.3 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
| 0.1 | 3.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 1.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.1 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 3.1 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.5 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 1.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 58.0 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.1 | 10.7 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 3.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
| 0.1 | 13.1 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.1 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 0.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.1 | 1.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 3.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 | 1.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 1.8 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.1 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 0.8 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 3.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 3.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 0.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 1.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.1 | 12.3 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.1 | 0.5 | GO:0051132 | NK T cell activation(GO:0051132) |
| 0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.2 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
| 0.1 | 2.2 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.1 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 2.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 2.4 | GO:0007033 | vacuole organization(GO:0007033) |
| 0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.8 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 | 0.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 1.1 | GO:0015992 | proton transport(GO:0015992) |
| 0.1 | 0.1 | GO:0046824 | positive regulation of nucleocytoplasmic transport(GO:0046824) |
| 0.1 | 1.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 0.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.2 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 5.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 | 2.1 | GO:0034310 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
| 0.1 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 2.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.1 | 0.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.7 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 | 0.3 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 3.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 1.4 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 3.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 3.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.6 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 1.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 1.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 2.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 1.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 0.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.1 | 1.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.1 | 2.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
| 0.1 | 1.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.1 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 2.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.9 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 9.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 3.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 1.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.7 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 1.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.9 | GO:0046132 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
| 0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.1 | 2.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.5 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.1 | 0.2 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 | 1.9 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.1 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 1.2 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
| 0.1 | 1.4 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
| 0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 0.6 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 | 0.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.4 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.1 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 | 0.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.1 | 0.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.2 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 | 0.2 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 | 1.0 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.3 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.2 | GO:0006979 | response to oxidative stress(GO:0006979) |
| 0.1 | 0.4 | GO:1901214 | regulation of neuron death(GO:1901214) |
| 0.1 | 3.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 1.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.1 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 1.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
| 0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
| 0.1 | 0.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 | 0.4 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.9 | GO:0051181 | cofactor transport(GO:0051181) |
| 0.1 | 0.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 3.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 | 0.8 | GO:0032637 | interleukin-8 production(GO:0032637) |
| 0.1 | 1.2 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.1 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 2.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.1 | 0.5 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
| 0.1 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.4 | GO:0031579 | membrane raft organization(GO:0031579) |
| 0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 0.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) protein-lipid complex assembly(GO:0065005) |
| 0.1 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.1 | 0.4 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 1.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 4.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.7 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 8.6 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 3.7 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.1 | 0.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.1 | 0.8 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.1 | 0.1 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.1 | 3.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 2.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.1 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 1.6 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 2.9 | GO:0006839 | mitochondrial transport(GO:0006839) |
| 0.1 | 0.8 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.1 | 7.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 0.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.5 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
| 0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 0.5 | GO:0097530 | granulocyte migration(GO:0097530) |
| 0.1 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.1 | 0.5 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.4 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.1 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
| 0.1 | 0.8 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.1 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 1.4 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
| 0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 3.0 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 1.2 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.2 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 | 6.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 1.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 | 0.8 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
| 0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.1 | 0.2 | GO:0090210 | detection of temperature stimulus involved in thermoception(GO:0050960) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
| 0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 2.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.1 | 0.3 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
| 0.1 | 1.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.1 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.1 | 0.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 1.1 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
| 0.1 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.2 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.1 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 | 0.3 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.0 | 0.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.0 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.7 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
| 0.0 | 0.8 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 0.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.0 | 0.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.2 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 | 4.6 | GO:0006914 | autophagy(GO:0006914) |
| 0.0 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 0.3 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.0 | 0.1 | GO:0098754 | detoxification(GO:0098754) |
| 0.0 | 0.6 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
| 0.0 | 0.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 3.0 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.0 | 0.1 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.0 | 0.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.0 | 0.2 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.0 | 0.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.0 | 1.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.3 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.0 | 0.2 | GO:0045453 | bone resorption(GO:0045453) |
| 0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 | 0.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 | 0.9 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
| 0.0 | 0.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.0 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 1.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.0 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.0 | 1.6 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.0 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
| 0.0 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.0 | 0.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
| 0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 1.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.0 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
| 0.0 | 0.1 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.0 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 | 0.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.0 | 0.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
| 0.0 | 0.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 | 0.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 2.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
| 0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
| 0.0 | 0.2 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.4 | GO:0031103 | axon regeneration(GO:0031103) |
| 0.0 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.1 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) protein localization to nucleoplasm(GO:1990173) |
| 0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 | 0.1 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.1 | GO:0046098 | guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.0 | 0.7 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.0 | 0.8 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 | 0.2 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
| 0.0 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 | 1.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
| 0.0 | 0.7 | GO:2001235 | positive regulation of apoptotic signaling pathway(GO:2001235) |
| 0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
| 0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.7 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
| 0.0 | 1.3 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.0 | 0.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.0 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.0 | 0.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
| 0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
| 0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
| 0.0 | 2.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.2 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.2 | GO:0007005 | mitochondrion organization(GO:0007005) |
| 0.0 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.4 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.1 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
| 0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.1 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.0 | 0.0 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.0 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 14.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.9 | 7.5 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 1.4 | 5.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.3 | 5.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.2 | 9.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 1.1 | 3.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 1.1 | 3.3 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 1.1 | 8.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.0 | 14.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.0 | 14.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.0 | 2.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 1.0 | 4.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.0 | 7.8 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.9 | 5.6 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.9 | 5.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.9 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.9 | 24.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.9 | 5.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.9 | 7.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.9 | 15.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.9 | 4.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.9 | 3.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.9 | 6.1 | GO:0005844 | polysome(GO:0005844) |
| 0.9 | 4.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.9 | 5.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.8 | 3.4 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.8 | 6.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.8 | 3.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.8 | 7.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.8 | 4.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.8 | 5.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.8 | 2.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.8 | 8.0 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.8 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.7 | 5.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.7 | 9.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.7 | 2.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.7 | 7.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.7 | 2.1 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.7 | 2.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.7 | 3.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.7 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 3.5 | GO:0071942 | XPC complex(GO:0071942) |
| 0.7 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.7 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.7 | 4.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.7 | 1.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.7 | 6.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.7 | 2.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.7 | 7.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.7 | 9.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.6 | 39.0 | GO:0043034 | costamere(GO:0043034) |
| 0.6 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.6 | 3.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.6 | 6.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.6 | 2.4 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.6 | 5.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.6 | 14.0 | GO:0005861 | troponin complex(GO:0005861) |
| 0.6 | 2.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.6 | 2.3 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.6 | 4.6 | GO:0070695 | FHF complex(GO:0070695) |
| 0.6 | 12.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.6 | 17.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.6 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.6 | 3.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.6 | 18.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.6 | 1.7 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.5 | 5.5 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.5 | 2.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.5 | 1.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.5 | 3.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.5 | 9.1 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.5 | 3.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.5 | 0.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.5 | 7.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.5 | 7.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.5 | 4.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.5 | 4.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 14.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.5 | 4.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.5 | 0.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.5 | 12.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.5 | 24.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.5 | 3.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.5 | 2.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 3.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.5 | 1.5 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.5 | 9.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.5 | 10.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.5 | 3.8 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.5 | 5.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.5 | 4.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.5 | 7.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.5 | 2.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.5 | 5.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.5 | 2.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.5 | 3.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.5 | 4.6 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.5 | 3.6 | GO:0071203 | WASH complex(GO:0071203) |
| 0.5 | 1.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.5 | 1.8 | GO:0030891 | VCB complex(GO:0030891) |
| 0.5 | 2.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 12.1 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.4 | 1.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.4 | 22.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.4 | 4.9 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 3.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 13.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.4 | 33.7 | GO:0031672 | A band(GO:0031672) |
| 0.4 | 2.6 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.4 | 4.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.4 | 2.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.4 | 8.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.4 | 2.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.4 | 2.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.4 | 5.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.4 | 2.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.4 | 2.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.4 | 5.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.4 | 2.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.4 | 4.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.4 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 0.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.4 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.4 | 10.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.4 | 3.2 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.4 | 11.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.4 | 2.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.4 | 8.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.4 | 2.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.4 | 2.7 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.4 | 2.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 27.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 3.0 | GO:0031415 | NatA complex(GO:0031415) |
| 0.4 | 4.5 | GO:0072487 | MSL complex(GO:0072487) |
| 0.4 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 42.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.4 | 3.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 3.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 20.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.4 | 1.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 37.3 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.4 | 12.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.4 | 1.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 12.7 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 5.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.4 | 1.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.4 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
| 0.4 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.4 | 4.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.4 | 1.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 2.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 2.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 2.8 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 2.1 | GO:0031310 | intrinsic component of endosome membrane(GO:0031302) intrinsic component of vacuolar membrane(GO:0031310) |
| 0.3 | 5.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.3 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 2.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 5.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.3 | 3.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 1.0 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.3 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 1.0 | GO:0034657 | GID complex(GO:0034657) |
| 0.3 | 3.6 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 9.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 1.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 1.9 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 7.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.3 | 1.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 4.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.3 | 3.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.3 | 0.9 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.3 | 23.7 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.3 | 1.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.3 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.3 | 4.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.3 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.3 | 3.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.3 | 1.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.3 | 27.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 6.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.3 | 7.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 11.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.3 | 0.9 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 3.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.3 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 1.4 | GO:0000805 | X chromosome(GO:0000805) |
| 0.3 | 1.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.3 | 7.5 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.3 | 2.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.3 | 25.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.3 | 0.3 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.3 | 5.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 7.9 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.3 | 49.7 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.3 | 7.0 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 3.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 4.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.3 | 1.4 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.3 | 0.3 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.3 | 6.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.3 | 2.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.3 | 6.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.3 | 1.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 20.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 3.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 17.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.3 | 18.7 | GO:0032994 | protein-lipid complex(GO:0032994) |
| 0.3 | 8.4 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.3 | 159.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.3 | 1.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.3 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 2.3 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.3 | 4.9 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.3 | 6.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 16.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 2.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 26.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 1.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 12.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.2 | 6.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 0.7 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 1.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.2 | 5.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 8.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 26.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.2 | 3.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 2.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 5.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.2 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.2 | 3.9 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 1.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 18.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.2 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 5.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 9.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 0.4 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 5.5 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.2 | 34.1 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 2.0 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 1.1 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.2 | 1.5 | GO:0034448 | EGO complex(GO:0034448) |
| 0.2 | 0.9 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 7.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 2.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 10.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.2 | 45.3 | GO:0030016 | myofibril(GO:0030016) |
| 0.2 | 9.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 4.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.2 | 2.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 2.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 5.1 | GO:0043218 | compact myelin(GO:0043218) |
| 0.2 | 1.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 81.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.2 | 2.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 2.0 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 3.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 9.4 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 1.0 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 3.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 2.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 1.3 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 4.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 2.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 2.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 20.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.2 | 0.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.2 | 2.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 17.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 3.3 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.2 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 23.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 7.4 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.2 | 1.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 2.0 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 0.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.2 | 5.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 0.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 2.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 18.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 0.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.2 | 1.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 8.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 3.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 0.7 | GO:0031213 | RSF complex(GO:0031213) |
| 0.2 | 0.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.2 | 3.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.2 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 1.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 0.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 2.6 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 5.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.2 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 51.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 0.5 | GO:0097526 | U6 snRNP(GO:0005688) spliceosomal tri-snRNP complex(GO:0097526) |
| 0.2 | 2.9 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 8.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 10.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 6.0 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 1.5 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 18.8 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.2 | 2.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.2 | 11.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.0 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 14.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 1.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.3 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.1 | 4.4 | GO:0005768 | endosome(GO:0005768) |
| 0.1 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.4 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 3.4 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 3.8 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.4 | GO:0043601 | nuclear replisome(GO:0043601) |
| 0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 9.3 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 69.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.1 | 0.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 2.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 2.2 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.1 | 1.5 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 0.4 | GO:0008623 | CHRAC(GO:0008623) |
| 0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.5 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.1 | 0.7 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 0.3 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 122.5 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 2.9 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.1 | 9.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 2.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 2.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 1.0 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.1 | 0.6 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 0.5 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 12.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 4.8 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 3.4 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 3.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.1 | 1.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 6.0 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 8.3 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 10.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.3 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.1 | 27.3 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 6.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 4.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.1 | 0.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 5.0 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.1 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 17.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 1.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 3.9 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 12.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 9.5 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.1 | 3.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 2.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.1 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 1.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.3 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.1 | 1.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 200.1 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.1 | 3.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 24.9 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 12.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.1 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 7.1 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 2.2 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 10.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.0 | 34.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.0 | 107.5 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.5 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 4.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.9 | GO:0070160 | occluding junction(GO:0070160) |
| 0.0 | 0.0 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 11.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 3.6 | 10.8 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 3.1 | 9.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 3.1 | 9.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 2.9 | 17.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 2.5 | 12.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 2.3 | 6.8 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 2.2 | 8.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 2.2 | 6.7 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 2.2 | 17.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 2.0 | 8.1 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 2.0 | 10.1 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 1.7 | 5.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.7 | 5.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.7 | 10.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.5 | 13.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.5 | 5.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 1.5 | 4.4 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 1.4 | 4.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 1.4 | 4.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.4 | 7.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.4 | 7.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 1.2 | 3.7 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.2 | 13.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.2 | 6.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.2 | 10.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 1.2 | 3.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 1.2 | 3.5 | GO:0030395 | lactose binding(GO:0030395) |
| 1.2 | 8.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.1 | 4.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.1 | 4.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.0 | 3.1 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 1.0 | 3.1 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 1.0 | 3.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 1.0 | 9.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.0 | 3.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 1.0 | 9.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.0 | 3.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 1.0 | 4.1 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 1.0 | 3.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 1.0 | 5.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.0 | 7.0 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 1.0 | 5.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 1.0 | 4.0 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.0 | 8.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.0 | 17.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 1.0 | 4.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.0 | 11.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.0 | 2.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.9 | 2.8 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.9 | 5.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.9 | 5.6 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.9 | 2.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.9 | 15.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.9 | 4.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.9 | 23.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.9 | 6.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.9 | 2.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.9 | 4.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.9 | 3.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.9 | 4.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.9 | 2.6 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.9 | 2.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.9 | 3.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.9 | 3.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.9 | 5.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.9 | 12.0 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.9 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.9 | 2.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.8 | 3.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.8 | 3.4 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.8 | 9.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.8 | 2.5 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.8 | 5.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.8 | 2.5 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.8 | 2.5 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.8 | 2.5 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.8 | 4.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.8 | 7.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.8 | 4.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.8 | 3.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.8 | 2.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 0.8 | 5.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.8 | 3.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.8 | 0.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.8 | 3.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.8 | 2.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.8 | 19.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.8 | 6.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.8 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.7 | 3.7 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.7 | 9.0 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.7 | 7.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.7 | 2.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.7 | 2.1 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.7 | 5.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.7 | 2.8 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.7 | 1.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.7 | 2.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.7 | 6.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.7 | 4.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.7 | 3.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.7 | 6.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.7 | 4.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.7 | 4.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.7 | 3.4 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.7 | 13.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.7 | 17.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.7 | 2.0 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.7 | 9.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.7 | 4.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.7 | 1.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.7 | 8.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.7 | 2.0 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.7 | 4.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.7 | 5.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 2.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.7 | 2.6 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.7 | 2.0 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.7 | 2.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.7 | 6.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.6 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 8.3 | GO:0015288 | porin activity(GO:0015288) |
| 0.6 | 3.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.6 | 5.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.6 | 1.9 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.6 | 5.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.6 | 1.9 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.6 | 1.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.6 | 2.5 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.6 | 1.9 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.6 | 6.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.6 | 5.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.6 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.6 | 5.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.6 | 2.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.6 | 4.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.6 | 1.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.6 | 2.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.6 | 5.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.6 | 1.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.6 | 4.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.6 | 1.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.6 | 2.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.6 | 1.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.6 | 9.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.6 | 5.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.6 | 1.7 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.6 | 5.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.6 | 2.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.6 | 7.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.6 | 1.7 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.6 | 1.7 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.6 | 2.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.6 | 2.3 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.6 | 7.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.6 | 1.7 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.5 | 1.6 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.5 | 5.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.5 | 1.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.5 | 5.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.5 | 11.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.5 | 9.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 4.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 4.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.5 | 2.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.5 | 6.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.5 | 1.6 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.5 | 3.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.5 | 1.6 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.5 | 2.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.5 | 10.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.5 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.5 | 2.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.5 | 6.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.5 | 29.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.5 | 4.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.5 | 2.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.5 | 2.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 4.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 1.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.5 | 2.6 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.5 | 3.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.5 | 3.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.5 | 2.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.5 | 1.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.5 | 3.5 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.5 | 4.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.5 | 3.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.5 | 16.9 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.5 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.5 | 4.5 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 8.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.5 | 2.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.5 | 0.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.5 | 3.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.5 | 8.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.5 | 3.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.5 | 1.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.5 | 2.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.5 | 1.5 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.5 | 3.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.5 | 1.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.5 | 1.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.5 | 1.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.5 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.5 | 6.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.5 | 1.9 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.5 | 1.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.5 | 6.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.5 | 4.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.5 | 16.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.5 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.5 | 6.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.5 | 1.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 3.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.5 | 2.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.5 | 1.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.5 | 1.8 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.5 | 1.8 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.5 | 7.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.5 | 3.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.5 | 2.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.5 | 1.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.5 | 26.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.4 | 1.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 1.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.4 | 2.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 1.3 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.4 | 5.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 1.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.4 | 4.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.4 | 27.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.4 | 3.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.4 | 0.4 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.4 | 8.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.4 | 12.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.4 | 3.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.4 | 1.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.4 | 1.3 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.4 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 1.7 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.4 | 1.3 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.4 | 3.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.4 | 6.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.4 | 2.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.4 | 6.8 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.4 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.4 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.4 | 3.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 1.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.4 | 13.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.4 | 1.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.4 | 8.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.4 | 3.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.4 | 3.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.4 | 2.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.4 | 2.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.4 | 1.2 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.4 | 4.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 4.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.4 | 4.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.4 | 1.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 19.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 1.6 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.4 | 4.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.4 | 3.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.4 | 9.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.4 | 2.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.4 | 9.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.4 | 1.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.4 | 3.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.4 | 1.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 3.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 2.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.4 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 0.8 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.4 | 1.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.4 | 1.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.4 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.4 | 18.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.4 | 15.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.4 | 9.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.4 | 0.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.4 | 0.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.4 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.4 | 8.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 5.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 3.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.4 | 3.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.4 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.4 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.4 | 8.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.4 | 7.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.4 | 1.5 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.4 | 6.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.4 | 2.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.4 | 2.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.4 | 3.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.4 | 2.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 0.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.4 | 1.8 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.4 | 10.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 1.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.4 | 1.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 2.5 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 1.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.4 | 1.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.4 | 1.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.3 | 1.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.3 | 1.0 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.3 | 7.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.3 | 2.1 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 3.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.3 | 1.4 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 2.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.3 | 1.0 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 10.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.3 | 2.0 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.3 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.3 | 5.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 4.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.3 | 3.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 0.7 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.3 | 1.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.3 | 8.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 1.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.3 | 4.7 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.3 | 1.0 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.3 | 2.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.3 | 1.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.3 | 3.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.3 | 1.0 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.3 | 1.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.3 | 2.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.3 | 1.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.3 | 1.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.3 | 7.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 0.6 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.3 | 4.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.3 | 5.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 0.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.3 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 0.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.3 | 1.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.3 | 1.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 1.3 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 3.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.3 | 2.5 | GO:0052659 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
| 0.3 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.3 | 0.6 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.3 | 1.9 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
| 0.3 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 19.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.3 | 3.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 2.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.3 | 1.5 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.3 | 0.9 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.3 | 1.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 1.8 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.3 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 4.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.3 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.3 | 11.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.3 | 4.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 18.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.3 | 1.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 0.9 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.3 | 1.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 6.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.3 | 7.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.3 | 9.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.3 | 0.9 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.3 | 3.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.3 | 0.9 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.3 | 1.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 7.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.3 | 0.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.3 | 4.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.3 | 1.1 | GO:0004803 | transposase activity(GO:0004803) |
| 0.3 | 1.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 0.9 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.3 | 9.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.3 | 1.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 1.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.3 | 1.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 4.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.3 | 1.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.3 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.3 | 1.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.3 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 12.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 8.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.3 | 0.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.3 | 1.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 12.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 5.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 1.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 2.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 4.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.3 | 8.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.3 | 2.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 1.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.3 | 5.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 6.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 5.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.3 | 1.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.3 | 6.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.3 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.3 | 7.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 2.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.3 | 22.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.3 | 8.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.3 | 0.8 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.3 | 2.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 0.8 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.3 | 0.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
| 0.3 | 5.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.3 | 3.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.3 | 1.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 2.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.3 | 7.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.3 | 2.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.3 | 7.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.3 | 1.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.3 | 1.0 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.3 | 4.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 3.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 0.3 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.3 | 0.5 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.3 | 0.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.3 | 1.8 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.2 | 0.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 2.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 0.7 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.2 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.2 | 8.4 | GO:0043236 | laminin binding(GO:0043236) |
| 0.2 | 2.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 0.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 13.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.2 | 6.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 9.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 1.0 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.2 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 1.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 0.7 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.2 | 0.7 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.2 | 2.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.2 | 1.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 0.7 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.2 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 0.7 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.2 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.2 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.2 | 0.7 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.2 | 0.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 8.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 0.7 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.2 | 6.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 3.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 1.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.2 | 1.4 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.2 | 0.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 1.2 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.2 | 17.7 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 0.9 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.2 | 3.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 2.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.2 | 1.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.2 | 8.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 3.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 7.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.2 | 2.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.2 | 3.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 2.2 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.2 | 1.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 4.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.2 | 12.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 4.2 | GO:0071949 | FAD binding(GO:0071949) |
| 0.2 | 53.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 1.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 2.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.2 | 5.8 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.2 | 3.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 0.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.2 | 0.6 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 9.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 0.8 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 1.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 2.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 3.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.2 | 0.6 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 0.8 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.2 | 1.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 0.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 0.6 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.2 | 8.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 2.0 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 3.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 6.3 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 10.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 0.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 1.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.2 | 2.7 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 2.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 1.2 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 5.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.2 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 6.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 1.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.2 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 3.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 1.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 1.5 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 5.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 5.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 2.6 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.9 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 16.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 4.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 6.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 3.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.2 | 2.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 6.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 2.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 8.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.5 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 4.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 0.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 0.5 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.2 | 3.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 1.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.2 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 3.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
| 0.2 | 0.5 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.2 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 0.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.2 | 0.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.2 | 82.3 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.2 | 4.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 9.4 | GO:0043621 | protein self-association(GO:0043621) |
| 0.2 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.2 | 2.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 3.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 3.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.2 | 0.7 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.2 | 3.2 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 2.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 0.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.2 | 2.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 2.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 12.0 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.2 | 0.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.2 | 0.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.2 | 2.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
| 0.2 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 5.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.2 | 0.3 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.2 | 0.5 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.2 | 1.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 3.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 0.5 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
| 0.2 | 1.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 7.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.2 | 1.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.2 | 6.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.2 | 1.4 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 3.5 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.2 | 0.5 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.2 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 1.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 4.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 1.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 1.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 1.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.2 | 0.9 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
| 0.2 | 0.5 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 3.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 1.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.2 | 11.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.2 | 0.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.2 | 0.3 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.2 | 44.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.2 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.2 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 0.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.2 | 4.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 5.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 5.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 4.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 5.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.6 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 3.1 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 0.6 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 0.4 | GO:0004794 | L-serine ammonia-lyase activity(GO:0003941) L-threonine ammonia-lyase activity(GO:0004794) |
| 0.1 | 5.0 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 6.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 10.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.4 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.1 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 3.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.6 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.1 | 0.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.1 | 3.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 1.4 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.1 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 17.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 2.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.1 | 3.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 9.4 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.8 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 3.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 3.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 6.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 1.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
| 0.1 | 4.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.1 | 5.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 3.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 17.3 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 1.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 39.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 4.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 4.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.1 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 3.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 1.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 7.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 1.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 24.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.1 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 6.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.1 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 6.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.1 | 5.2 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 2.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.9 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.1 | 12.0 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 0.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 3.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 1.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 5.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 3.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.4 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 2.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 7.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 1.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 0.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.1 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 1.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 1.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.1 | 1.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 3.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 6.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.4 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
| 0.1 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 18.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.8 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 2.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 5.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 2.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 6.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 2.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 13.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 2.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 0.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 2.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 3.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.1 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.1 | 0.2 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.1 | 0.1 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.1 | 0.4 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 1.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 9.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 1.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 1.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 2.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.4 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 13.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 4.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 0.2 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.1 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.5 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 10.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.1 | 0.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 1.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 1.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 2.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 12.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.7 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 4.9 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
| 0.0 | 4.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.0 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
| 0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.0 | 0.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.0 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 1.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 1.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 1.6 | GO:0017016 | Ras GTPase binding(GO:0017016) |
| 0.0 | 11.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 5.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.0 | 1.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 7.4 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 2.3 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.0 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
| 0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.0 | 0.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 0.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 0.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 9.9 | GO:0008270 | zinc ion binding(GO:0008270) |
| 0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.1 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.0 | 0.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.4 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 1.1 | 22.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.0 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.9 | 42.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.6 | 7.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.6 | 41.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.6 | 33.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.5 | 31.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.5 | 25.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.5 | 27.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.5 | 38.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.5 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.5 | 1.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.5 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.5 | 22.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.5 | 18.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.5 | 10.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.5 | 3.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.5 | 8.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.5 | 23.7 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 16.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.4 | 1.8 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.4 | 15.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.4 | 21.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.4 | 45.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.4 | 2.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.4 | 12.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.4 | 25.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.4 | 20.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.4 | 4.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 9.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.3 | 28.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.3 | 3.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 14.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 6.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.3 | 11.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 22.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.3 | 19.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.3 | 8.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 34.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 3.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.3 | 2.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.3 | 5.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 4.5 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 3.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 19.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.2 | 2.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 3.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 12.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 22.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.2 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 3.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.2 | 17.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 6.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.2 | 13.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 3.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 14.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 10.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 10.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 13.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.2 | 1.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.2 | 19.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.2 | 10.9 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 3.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 8.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 1.1 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 5.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 17.9 | PID P73PATHWAY | p73 transcription factor network |
| 0.2 | 4.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 0.8 | ST ADRENERGIC | Adrenergic Pathway |
| 0.2 | 4.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 9.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 9.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.2 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 11.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 4.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 3.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 5.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 4.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 6.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 1.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 3.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 14.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 3.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 3.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 7.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 4.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 3.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 2.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 1.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 6.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 2.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 2.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 3.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 2.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 4.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 3.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 3.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 7.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 3.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 2.9 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 1.1 | 24.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 1.0 | 25.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 1.0 | 23.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.9 | 17.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.8 | 24.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.8 | 32.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.8 | 21.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.7 | 31.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.7 | 10.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.6 | 1.9 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.6 | 5.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.6 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.6 | 11.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.6 | 25.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.6 | 10.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.6 | 6.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.5 | 3.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.5 | 22.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.5 | 17.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.5 | 11.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 29.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.5 | 25.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.5 | 14.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.5 | 12.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.5 | 6.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.5 | 13.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.5 | 22.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.5 | 1.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.5 | 12.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 4.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 20.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.4 | 16.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.4 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 44.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.4 | 31.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.4 | 16.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.4 | 11.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 10.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.4 | 17.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.4 | 4.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.4 | 8.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.4 | 30.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.4 | 11.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 30.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.4 | 37.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.4 | 25.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.4 | 13.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 2.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 8.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 10.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.3 | 8.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.3 | 9.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 13.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.3 | 14.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.3 | 1.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.3 | 12.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.3 | 4.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.3 | 11.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.3 | 4.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.3 | 4.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.3 | 7.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.3 | 6.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 15.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.3 | 5.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.3 | 5.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.3 | 10.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.3 | 23.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 2.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.3 | 28.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.3 | 5.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.3 | 2.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.3 | 4.8 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.3 | 5.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.3 | 12.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 11.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 8.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 8.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.2 | 8.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 12.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 1.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 19.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 21.9 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
| 0.2 | 7.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 3.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 5.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 25.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 4.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 7.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 6.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 1.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.2 | 2.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 12.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 5.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 3.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 3.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 4.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.2 | 10.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 2.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 2.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.2 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 5.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 8.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.2 | 13.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.2 | 3.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 2.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 1.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 1.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 6.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 6.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 29.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 3.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 0.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.2 | 7.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 7.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 0.2 | 1.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 4.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 40.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 20.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.2 | 4.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 3.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 5.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 4.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 1.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 3.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 2.7 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
| 0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 19.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 4.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 5.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 5.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.1 | 3.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 13.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 3.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 5.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 4.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 6.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 6.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 3.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 5.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 1.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 3.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 9.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 2.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 4.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 1.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 0.7 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
| 0.1 | 5.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 3.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.1 | 1.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 2.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.1 | 5.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 4.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 12.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 7.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 3.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 1.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 4.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 1.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 1.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 7.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 1.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 1.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 1.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.0 | 2.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.0 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 7.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 2.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.0 | 1.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.0 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |